Inventor
BJORDAHL RYAN
US18 patents
Patents
18 patentsUS10858628B2Dec 8, 2020
Methods and compositions for inducing hematopoietic cell differentiation
FATE THERAPEUTICS INC15 citations93
US11365394B2Jun 21, 2022
Enhanced immune effector cells and use thereof
FATE THERAPEUTICS INC14 citations92
US11072781B2Jul 27, 2021
Genomic engineering of pluripotent cells
FATE THERAPEUTICS INC18 citations92
US10927346B2Feb 23, 2021
Enhanced immune effector cells and use thereof
FATE THERAPEUTICS INC17 citations92
US10287606B2May 14, 2019
Genomic engineering of pluripotent cells
FATE THERAPEUTICS INC28 citations92
US11162075B2Nov 2, 2021
Methods and compositions for inducing hematopoietic cell differentiation
FATE THERAPEUTICS INC5 citations83
US11162076B2Nov 2, 2021
Methods and compositions for inducing hematopoietic cell differentiation
FATE THERAPEUTICS INC7 citations83
US10947505B2Mar 16, 2021
Methods and compositions for inducing hematopoietic cell differentiation
FATE THERAPEUTICS INC8 citations83
US11352607B2Jun 7, 2022
Genomic engineering of pluripotent cells
FATE THERAPEUTICS INC2 citations71
US11096964B2Aug 24, 2021
Compositions and methods for immune cell modulation in adoptive immunotherapies
FATE THERAPEUTICS INC4 citations71
US11413309B2Aug 16, 2022
Compositions and methods for immune cell modulation in adoptive immunotherapies
FATE THERAPEUTICS INC4 citations70
US12435123B2Oct 7, 2025
Immunotherapies using enhanced iPSC derived effector cells
FATE THERAPEUTICS INC0 citations62
US12410403B2Sep 9, 2025
Methods and compositions for inducing hematopoietic cell differentiation
FATE THERAPEUTICS INC0 citations62
US12398373B2Aug 26, 2025
Enhanced immune effector cells and use thereof
FATE THERAPEUTICS INC0 citations61
US12173274B2Dec 24, 2024
Enhanced immune effector cells and use thereof
FATE THERAPEUTICS INC0 citations61
US12281329B2Apr 22, 2025
Compositions and methods for immune cell modulation in adoptive immunotherapies
FATE THERAPEUTICS INC0 citations60
US12275955B2Apr 15, 2025
Combining iPSC derived effector cell types for immunotherapy use
FATE THERAPEUTICS INC0 citations60
US12419870B2Sep 23, 2025
Compositions and methods for immune cell modulation in adoptive immunotherapies
FATE THERAPEUTICS INC0 citations59